The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAssura Regulatory News (AGR)

Share Price Information for Assura (AGR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 42.60
Bid: 42.54
Ask: 42.74
Change: -0.08 (-0.19%)
Spread: 0.20 (0.47%)
Open: 42.86
High: 42.86
Low: 42.60
Prev. Close: 42.68
AGR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Capital Markets Event

8 Feb 2024 14:00

RNS Number : 4858C
Assura PLC
08 February 2024

8 February 2024

Assura plc

Capital markets event

Assura plc ("Assura"), the leading primary care property investor and developer, is today hosting a capital markets presentation and site tour for analysts and institutional investors.

Assura has identified several areas of emerging opportunities (NHS Trusts, private providers, mental health and Ireland) that are now becoming meaningful contributors to our portfolio, rental income and cash flow.

Members of the senior management team will present an update on our strategic approach to these emerging opportunities, outlining why we are targeting these areas alongside our existing GP medical centres and how our skills and capabilities mean we are well placed to become a market leader.

Specifically focused on the private market, the presentation will detail:

· The state of the UK healthcare market and resultant increasing demand for high-quality, sustainable healthcare buildings in a community setting

· Overview of trends and market opportunity in the private market segment

· Assura's capabilities in capturing this opportunity; to complement its existing GP centre portfolio

· An overview of recent private market development completions

· Recent investments and asset enhancements within the mental health segment will also be highlighted

There will be a subsequent site tour to showcase Assura's recently completed, state-of-the-art cancer care facility in Guildford.

Jonathan Murphy, CEO of Assura, said: "There is significant demand for high-quality, sustainable healthcare buildings in a community setting to alleviate the considerable and growing pressures facing the NHS whilst improving the significantly underinvested existing estate. Each of these emerging areas is closely aligned with Assura's existing portfolio to relieve pressure on the health system; has attractive investment characteristics with a strong underlying tenant covenant and offers opportunities for future growth, which Assura is well placed to capture."

No new material trading information will be disclosed. A copy of the presentation is available on the Assura plc website at: https://www.assuraplc.com/investor-relations/reports-and-presentations

- ENDS -

Assura plc David Purcell, Investor Relations Director

Tel: 0161 515 2043 Email: Investor@assura.co.uk

FGS Global

Gordon SimpsonGrace Whelan

Tel: 0207 251 3801 Email: Assura@fgsglobal.com

Notes to Editors

Assura plc is a national healthcare premises specialist and UK REIT based in Altrincham, UK - caring for more than 600 primary healthcare buildings, from which over six million patients are served.

A constituent of the FTSE 250 and the EPRA* indices, as at 30 September 2023, Assura's portfolio was valued at £2.7 billion.

At Assura, we BUILD for health. Assura builds better spaces for people and places, invests in skills and inspires new ways of working, and unlocks the power of design and innovation to deliver lasting impact for communities - aiming for six million people to have benefitted from improvements to and through its healthcare buildings by 2026.

Assura is leading for a sustainable future, targeting net zero carbon across its portfolio by 2040.

Further information is available at www.assuraplc.com

*EPRA is a registered trademark of the European Public Real Estate Association.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
UPDUWAWRSBUURRR
Date   Source Headline
16th Oct 20177:00 amRNSScrip Dividend Declaration
10th Oct 20177:00 amRNSAppointment of Non-Executive Director
3rd Oct 20173:01 pmRNSDirectorate Change
2nd Oct 20171:07 pmRNSNotification of Major Interests in Shares
2nd Oct 20177:00 amRNSTrading Update
25th Sep 20177:00 amRNSChief Financial Officer
21st Sep 201712:21 pmRNSScrip Calculation Price
11th Sep 20174:23 pmRNSNotification of Major Interests in Shares
8th Sep 20175:20 pmRNSPDMR Notification
7th Sep 20177:00 amRNSNotice of Dividend - Property Income Distribution
1st Sep 201711:42 amRNSTotal Voting Rights
1st Sep 201710:30 amRNSExercise of Nil Cost Options under VCP
30th Aug 20177:00 amRNSAdditional Listing
21st Aug 20171:44 pmRNSAppointment of Joint Corporate Broker
17th Aug 201712:05 pmRNSNotification of Major Interest in Shares
4th Aug 20177:00 amRNSAppointment of Chief Financial Officer
1st Aug 20177:00 amRNSTotal Voting Rights
19th Jul 20174:41 pmRNSNotification of Transactions by PDMRs
18th Jul 20172:27 pmRNSResult of AGM
18th Jul 20177:00 amRNSTrading Update
17th Jul 20177:00 amRNSScrip Dividend Declaration
3rd Jul 20179:20 amRNSCorrection of Total Voting Rights
3rd Jul 20177:00 amRNSTotal Voting Rights
22nd Jun 201711:14 amRNSScrip Calculation Price
22nd Jun 201710:14 amRNSNotification of Major Interests in Shares
22nd Jun 201710:11 amRNSNotification of Major Interests in Shares
20th Jun 20174:52 pmRNSResults of Placing
20th Jun 20177:00 amRNSProposed equity Issue of new ordinary shares
16th Jun 20174:00 pmRNSAnnual Report and Notice of AGM
16th Jun 20173:12 pmRNSNotification of Major Interests in Shares
13th Jun 20172:56 pmRNSNotification of Major Interests in Shares
8th Jun 20177:00 amRNSNotice of Dividend
5th Jun 20174:55 pmRNSNotification of transaction by PDMR
30th May 20177:00 amRNSDirector Declaration
24th May 201711:29 amRNSCorrection of Dividend Information
23rd May 20177:00 amRNSAssura Full Year Results
12th May 201711:00 amRNSNotification of Major Interests in Shares
11th May 20172:46 pmRNSNotification of Major Interests in Shares
2nd May 20177:00 amRNSTotal Voting Rights
18th Apr 20177:00 amRNSScrip Dividend Declaration
11th Apr 20174:29 pmRNSNotification of Major Interest in Shares
24th Mar 20174:15 pmRNSScrip Calculation Price
9th Mar 20177:00 amRNSNotice of Dividend
27th Feb 20177:00 amRNSAppointment of CEO
17th Feb 20173:07 pmRNSNotification of Major Interest in Shares
1st Feb 201712:54 pmRNSTotal Voting Rights
1st Feb 20177:00 amRNSTrading Update
26th Jan 20179:18 amRNSNotification of Major Interest in Shares
18th Jan 20177:00 amRNSNotification of Transaction by PDMR
16th Jan 20177:00 amRNSScrip Dividend Declaration

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.